Over 650 abstracts were submitted a record-breaking number for ISCT showcasing the state of the art across the field of CGT translation. Thank you to all those who presented their work at ISCT 2023, and congratulations to the ISCT 2023 Abstract Award Winners.
Interested in another opportunity to showcase your research? You can also submit your ISCT 2023 Paris Abstracts to our upcoming North America Regional Meeting in September. Submit before June 19th and join us in Houston!
Hannah Song, PhD National Institutes of Health, USA
"CAR-T Cells Manufactured via Positive and Negative Immunomagnetic T Cell Selection Show Different Tumour Killing Rates, Cytokine Profiles, and γδ T Cell Output."
Marco Alessandrini, PhDAntion Biosciences, Switzerland
"Overcoming the Risk of Graft Versus Host Disease by Engineering Non-Alloreactive T-Cells Using a Tunable Expression Module (Tem) for High Efficiency Gene Silencing"
Jiri Eitler, PhDTU Dresden, Germany
"Dual Targeting of CAR-NK Cells to PDL1 and HER2 Facilities Specific Elimination of Cancer Cells of Solid Tumor Origin and Overcomes Immune Escape by Antigen Loss"
Nasser Masroori, PhDLe Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, University of Montreal, Canada
"Engineering T Cell Targeting Minor Histocompatibility Antigens"
Paramita Chatterjee, MSc, MBAGeorgia Institute of Technology, USA
"Single-Cell Transcriptomics Comparison Of Cell Therapeutics in Osteoarthritis"
Ashley Geiger, BSc, MSCChildren's National Medical Center, USA
"Multi-Tumor Associated Antigen-Specific T Cell (Taa-T) Therapy to Treat Pediatric Patients With High-Risk Cns Tumors: The Remind Trial"
Corby Fink, PhD
Western University; Robarts Research Institute, Canada
"In Vivo Tracking of Adenoviral-Transduced SPIO-labeled Bone Marrow-Derived Dendritic Cells Using MPI"
Laura Baque Vidal, MSc
Karolinska Institute, Sweden
"Manufacture And Release Testing Of Cellthrpe1 for Treatment Of Dry Age-Related Macular Degeneration"
Matheus Henrique dos Santos, MScUniversity of São Paulo, Brazil
"Incorporation of 2b4 Signaling Domain in Anti-Cd19 Nk-Specific Cars Increases the Potency of Effector Functions Of Car-Nk Cells Against Malignant Cd19+ Cell Lines"
Alice Bertaina, MD, PhDStanford University School of Medicine, USA
"T-allo10 Infusion after Aβdepleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD"
Katie Lineburg, BSc, PhDQIMR Berghofer Medical Research Institute, Australia
"Harnessing Surface Expression to Define a Unique Memory T Cell Subset with Stem-Like Properties to Enhance Adoptive T Cell Therapies"
Fabrizia Bonacina, PhDUniversita degli Studi di Milano, Italy
"Generation of Humanized Immunocompromised Dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO Mice for the Study of Immunomodulatory Therapies for the Treatment of Atherosclerosis"
Tae-Yoon Park, PhDMcLean Hospital; Harvard Medical School Department of Psychiatry, USA
"Therapeutic Improvement of Parkinson’s Disease Transplantation Therapy Through Modulating the Immune System"
Kevin Robb, BSc, MEScUniversity of Toronto, Canada
"Patient Responses to Mesenchymal Stromal Cell (MSC) Therapy in Osteoarthritis are Associated with Differential Clinical Phenotypes, Molecular Endotypes, and MSC Critical Quality Attributes"
Denis Claude Roy, MDHopital Maisonnneuve-Rosemont; CR-HMR; Universite de Montreal Faculte de Medecine, Canada
"Phase I clinical Trial of Anti-Minor Histocompatibility Antigen Expanded T-Cells to Target Leukemia Relapsing after Allogeneic HLA-Matched Transplantation"
© 2021 ISCT. All rights reserved.
Site by eConverse Media